<?xml version='1.0' encoding='iso-8859-1'?>
<newsitem date="1997-03-05" id="root" itemid="419997" xml:lang="en">
<title>USA: ImmuLogic restructures board of directors.</title>
<headline>ImmuLogic restructures board of directors.</headline>
<dateline>WALTHAM, Mass. 1997-03-05</dateline>
<text>
<p>ImmuLogic Pharmaceutical Corp said it has restructured its board of directors and appointed five new members to the eight person board effective immediately.</p>
<p>They include acting president and chief executive J. Joseph Marr, Stanford University professor C. Garrison Fathman, Imclone Systems Inc chief financial officer Carl Goldfischer, Ibah Inc CEO Geraldine Henwood and Alkermes CEO Richard Pops.</p>
<p>It said these appointments follow the resignation of chairman Malcolm Gefter, Alan Dalby, Howard Jacobson, Kenneth Melmon and Larry Soll.</p>
<p>"This restructuring was done in consultation with several major stockholders with the purpose of adding pharmaceutical and business advisory capabilities to the board. The newly constituted board has the diversity of talent and experience needed to guide Immulogic at its present stage of development," acting president Joseph Marr said.</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<dc element="dc.date.created" value="1997-03-05" />
<dc element="dc.publisher" value="Reuters Holdings Plc" />
<dc element="dc.date.published" value="1997-03-05" />
<dc element="dc.source" value="Reuters" />
<dc element="dc.creator.location" value="WALTHAM, Mass." />
<dc element="dc.creator.location.country.name" value="USA" />
<dc element="dc.source" value="Reuters" />
</metadata>
</newsitem>